Functional Medicine
Testosterone Therapy and Breast Cancer Incidence Study
BHRT Study Shows 35.5% Lower Incidence of Breast Cancer in Women Treated with Subcutaneous Testosterone BioTE founder Gary Donovitz, MD, FACOG, and Mandy Cotten, DNP,
July 22, 2021
